Warhound raises $200M to genetically engineer and clone military working dogs
Warhound, backed by Colossal Biosciences' Ben Lamm and Anduril's Palmer Luckey, has raised $200 million to genetically edit and clone top-performing military, police and first-responder dogs, mostly Belgian Malinois. Lamm says the startup has begun editing genes from donor dog cell samples, initially targeting breed-specific health issues like hip dysplasia and cancer, with plans to later enhance traits like speed and smell. Anduril will supply protective gear such as vests and goggles rather than cybernetic enhancements, while Colossal holds equity and Lamm sits on Warhound's board.